Diagnostic Significance and Association of Reticulin Fibrosis in Benign Hematologic Disorders: Reticulin Fibrosis in Benign Disorders

Yasir Shabbir; Aisha Hameed; Rabia Chaudhry; Quratul Ain Ahmad; Uzma Waseem; Sajid Hameed

doi:10.54393/pjhs.v5i08.1670

Authors

Yasir Shabbir Department of Pathology, Gujranwala Medical College, Gujranwala, Pakistan
Aisha Hameed Department of Pathology, Gujranwala Medical College, Gujranwala, Pakistan
Rabia Chaudhry Department of Pathology, Lahore Medical and Dental College, Lahore, Pakistan
Quratul Ain Ahmad Department of Medicine, Al-Syed Surgical Hospital, Bhawalnagar, Pakistan
Uzma Waseem Department of Anatomy, Rahbar Medical and Dental College, Lahore, Pakistan
Sajid Hameed Department of Public Health , Green International University, Lahore, Pakistan

DOI:

https://doi.org/10.54393/pjhs.v5i08.1670

Keywords:

Anemia, Aplastic, Hematologic Disorders, Hemoglobinopathies, Megaloblastic

Abstract

Reticulin fibrosis is a feature of benign illnesses. Reticulin staining is used to identify benign hematological abnormalities in bone marrow, with trichrome staining being the most appropriate procedure for histological examinations. Objective: To assess the association of reticulin fibrosis to benign hematological disorders. Methods: Patients with benign hematologic illnesses such as iron deficiency anemia, megaloblastic anemia, aplastic anemia, and immune thrombocytopenic purpura at department of hematology, Sheikh Zayed Medical Complex, Lahore were included. The sample size was 96 cases, with 24 cases for each disorder. Bone marrow samples were taken from the anterior iliac spine of patients diagnosed with benign hematologic diseases. The reticulin fibers were graded using the Thiele grading scale. Results: The gender distribution was significant, with ITP and IDA being higher in females, whereas MA was more prevalent in men. The age distribution was almost the same, with ITP the lowest mean age was 40.5 years, while the highest mean age was 46.7 years in cases with aplastic anemia. Reticulin stain results showed significant differences among the four groups, with all cases in MA, IDA, and AA having grade-0 results. Conclusion: The reticulin stain can distinguish between ITP and other hematological illnesses, as well as grade reticulosis in bone marrow biopsies, making it a helpful tool for detecting benign hematological disorders.

References

Ghosh K, Shome DK, Kulkarni B, Ghosh MK, Ghosh K. Fibrosis and bone marrow: Understanding causation and pathobiology. Journal of Translational Medicine. 2023 Oct; 21(1): 703. doi: 10.1186/s12967-023-04393-z. DOI: https://doi.org/10.1186/s12967-023-04393-z

Joseph B, Samly SM, Varghese LA. Bone Marrow Profile in Haematological Disorders with reference to Flow Cytometry and RT-PCR in Acute Leukaemia. 2023 Jan-Mar; 12 (1): 14-18. doi: 10.1002/9781119398929. DOI: https://doi.org/10.1002/9781119398929

Verstovsek S, Savona MR, Mesa RA, Dong H, Maltzman JD, Sharma S et al. A phase 2 study of simtuzumab in patients with primary, post‐polycythaemia vera or post‐essential thrombocythaemia myelofibrosis. British Journal of Haematology. 2017 Mar; 176(6): 939-49. doi: 10.1111/bjh.14501. DOI: https://doi.org/10.1111/bjh.14501

Bradding P and Pejler G. The controversial role of mast cells in fibrosis. Immunological Reviews. 2018 Mar; 282(1): 198-231. doi: 10.1111/imr.12626. DOI: https://doi.org/10.1111/imr.12626

Bouri S and Martin J. Investigation of iron deficiency anaemia. Clinical Medicine. 2018 Jun; 18(3): 242-4. doi: 10.7861/clinmedicine.18-3-242. DOI: https://doi.org/10.7861/clinmedicine.18-3-242

Kumar SB, Arnipalli SR, Mehta P, Carrau S, Ziouzenkova O. Iron deficiency anemia: efficacy and limitations of nutritional and comprehensive mitigation strategies. Nutrients. 2022 Jul; 14(14): 2976. doi: 10.3390/nu14142976. DOI: https://doi.org/10.3390/nu14142976

Rusch JA, van der Westhuizen DJ, Gill RS, Louw VJ. Diagnosing iron deficiency: Controversies and novel metrics. Best Practice and Research Clinical Anaesthesiology. 2023 Nov. doi: 10.1016/j.bpa.2023.11.001. DOI: https://doi.org/10.1016/j.bpa.2023.11.001

Wernig G, Chen SY, Cui L, Van Neste C, Tsai JM, Kambham N et al. Unifying mechanism for different fibrotic diseases. Proceedings of the National Academy of Sciences. 2017 May; 114(18): 4757-62. doi: 10.1073/pnas.1621375114. DOI: https://doi.org/10.1073/pnas.1621375114

Uçar MA, Falay M, Dağdas S, Ceran F, Urlu SM, Özet G. The importance of RET-He in the diagnosis of iron deficiency and iron deficiency anemia and the evaluation of response to oral iron therapy. Journal of Medical Biochemistry. 2019 Oct; 38(4): 496. doi: 10.2478/jomb-2018-0052. DOI: https://doi.org/10.2478/jomb-2018-0052

Kiani AM, Khan AD, Saeed N, Ahmad SS, Khan W, Waseem R et al. Unveiling the Spectrum of Megaloblastic Anemia: Insights from a Multifaceted Study at Abbas Institute of Medical Sciences, Muzaffarabad. Journal of Health and Rehabilitation Research. 2023 Dec; 3(2): 500-5. doi.org/10.61919/jhrr.v3i2.190. DOI: https://doi.org/10.61919/jhrr.v3i2.190

Hedayanti N and Wahyudi A. Review of Physiological Aspects of Erythropoiesis: A Narrative Literature Review. Sriwijaya Journal of Internal Medicine. 2023 Apr; 1(1): 19-25. doi: 10.59345/sjim.v1i1.20. DOI: https://doi.org/10.59345/sjim.v1i1.20

Phoulady HA, Goldgof D, Hall LO, Mouton PR. Automatic ground truth for deep learning stereology of immunostained neurons and microglia in mouse neocortex. Journal of Chemical Neuroanatomy. 2019 Jul; 98: 1-7. doi: 10.1016/j.jchemneu.2019.02.006. DOI: https://doi.org/10.1016/j.jchemneu.2019.02.006

Socha DS, DeSouza SI, Flagg A, Sekeres M, Rogers HJ. Severe megaloblastic anemia: Vitamin deficiency and other causes. Cleveland Clinic Journal of Medicine. 2020 Mar; 87(3): 153-64. doi: 10.3949/ccjm.87a.19072. DOI: https://doi.org/10.3949/ccjm.87a.19072

Sudulagunta SR, Kumbhat M, Sodalagunta MB, Nataraju AS, Raja SK, Thejaswi KC et al. Warm autoimmune hemolytic anemia: clinical profile and management. Journal of Hematology. 2017 Mar; 6(1): 12. doi: 10.14740/jh303w. DOI: https://doi.org/10.14740/jh303w

Mohan A. Uncovering an Uncommon Outcome: A Case Report of Colchicine-Induced Aplastic Anemia. Journal of Bangladesh Medical Association of North America (BMANA) BMANA Journal. 2023 Jul: 1-7.

Pezeshki SM, Saki N, Ghandali MV, Ekrami A, Avarvand AY. Effect of Helicobacter Pylori eradication on patients with ITP: a meta-analysis of studies conducted in the Middle East. Blood Research. 2021 Mar; 56(1): 38-43. doi: 10.5045/br.2021.2020189. DOI: https://doi.org/10.5045/br.2021.2020189

Audia S, Mahévas M, Nivet M, Ouandji S, Bonnotte B. Immune thrombocytopenia: recent advances in pathogenesis and treatments. Hemasphere. 2021 Jun; 5(6): e574. doi: 10.1097/HS9.0000000000000574. DOI: https://doi.org/10.1097/HS9.0000000000000574

Cao-Sy L, Obara N, Sakamoto T, Kato T, Hattori K, Sakashita S et al. Prominence of nestin-expressing Schwann cells in bone marrow of patients with myelodysplastic syndromes with severe fibrosis. International Journal of Hematology. 2019 Mar; 109: 309-18. doi: 10.1007/s12185-018-02576-9. DOI: https://doi.org/10.1007/s12185-018-02576-9

Bashir N, Musharaf B, Reshi R, Jeelani T, Rafiq D, Angmo D. Bone marrow profile in hematological disorders: an experience from a tertiary care centre. International Journal of Advances in Medicine. 2018 May; 5(3): 608-13. doi: 10.18203/2349-3933.ijam20182111. DOI: https://doi.org/10.18203/2349-3933.ijam20182111

Munir AH, Khan MI, Rahman S. Frequency of hematological disorders in Peshawar by bone marrow aspiration and trephine biopsy examination. Pakistan Journal Of Surgery. 2019 Mar; 35(3): 230-3.

Wakahashi K, Minagawa K, Kawano Y, Kawano H, Suzuki T, Ishii S et al. Vitamin D receptor-mediated skewed differentiation of macrophages initiates myelofibrosis and subsequent osteosclerosis. Blood, The Journal of the American Society of Hematology. 2019 Apr; 133(15): 1619-29. doi: 10.1182/blood-2018-09-876615. DOI: https://doi.org/10.1182/blood-2018-09-876615

Bourgot I, Primac I, Louis T, Noël A, Maquoi E. Reciprocal interplay between fibrillar collagens and collagen-binding integrins: implications in cancer progression and metastasis. Frontiers in Oncology. 2020 Aug; 10: 1488. doi: 10.3389/fonc.2020.01488. DOI: https://doi.org/10.3389/fonc.2020.01488

Viola A, Munari F, Sánchez-Rodríguez R, Scolaro T, Castegna A. The metabolic signature of macrophage responses. Frontiers in Immunology. 2019 Jul; 10: 1462. doi: 10.3389/fimmu.2019.01462. DOI: https://doi.org/10.3389/fimmu.2019.01462

R. Hargreaves et al. Diagnostic and management strategies for Myeloproliferative Neoplasm-Unclassifiable (MPN-U): an international survey of contemporary practice Curr Res Transl Med. 2022 Jul. doi: 10.1016/j.retram.2022.103338. DOI: https://doi.org/10.1016/j.retram.2022.103338

Gleitz HF, Kramann R, Schneider RK. Understanding deregulated cellular and molecular dynamics in the haematopoietic stem cell niche to develop novel therapeutics for bone marrow fibrosis. The Journal of Pathology. 2018 Jun; 245(2): 138-46. doi: 10.1002/path.5078. DOI: https://doi.org/10.1002/path.5078

Wick MR. The hematoxylin and eosin stain in anatomic pathology-An often-neglected focus of quality assurance in the laboratory. InSeminars in Diagnostic Pathology. 2019 Sep; 36(5); 303-311. doi: 10.1053/j.semdp.2019.06.003. DOI: https://doi.org/10.1053/j.semdp.2019.06.003